Case Report: Hypercalcemia With Inappropriate 1,25-Dihydroxyvitamin D in Wegener’s Granulomatosis
- 1 August 1994
- journal article
- case report
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 308 (2), 115-118
- https://doi.org/10.1097/00000441-199408000-00011
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1–34) infusion test: An improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidismCalcified Tissue International, 1990
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- Regulation of 1,25 (OH)2D synthesis in hypoparathyroidism and pseudohypoparathyroidismAmerican Journal of Physiology-Endocrinology and Metabolism, 1988
- Parathyroid hormone-independent regulation of 1,25(OH)2D in response to inhibition of bone resorptionAmerican Journal of Physiology-Endocrinology and Metabolism, 1988
- Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans.JCI Insight, 1986
- Serum Protein Binding of 1,25-Dihydroxyvitamin D: A Reevaluation by Direct Measurement of Free Metabolite Levels*Journal of Clinical Endocrinology & Metabolism, 1985
- Hypercalcemia and Elevated 1,25-Dihydroxyvitamin D Levels in a Patient with End-Stage Renal Disease and Active TuberculosisNew England Journal of Medicine, 1984
- Hypercalcemia in disseminated candidiasisAmerican Journal Of Medicine, 1983
- Hypercalcemia in an Anephric Patient with Sarcoidosis: Evidence for Extrarenal Generation of 1,25-Dihydroxyvitamin DNew England Journal of Medicine, 1981
- Affinity chromatography with 25-hydroxycholecalciferol ester in the isolation of the binding protein for vitamin D and its metabolites from human serumMetabolic Bone Disease and Related Research, 1981